XML 111 R63.htm IDEA: XBRL DOCUMENT v3.23.1
Share-based Compensation (Details 2) - Stock Settled Stock Appreciation Rights (SSARS) [Member]
$ / shares in Units, $ in Thousands
12 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Number of Rights Outstanding at Beginning of Period | shares 2,172,939
Number of Rights Granted | shares 0
Number of Rights Exercised | shares (573,016)
Number of Rights, Forfeited | shares (27,463)
Number of Rights Expired | shares 0
Number of Rights Outstanding at End of Period | shares 1,572,460
Number of Rights Exercisable at End of Period | shares 1,572,460
Number of Rights Vested and expected to vest at March 31, 2022 | shares 1,572,460
Weighted Average Exercise Price Outstanding at Beginning of Period | $ / shares $ 24.02
Weighted Average Exercise Price, Granted | $ / shares 0
Weighted Average Exercise Price, Exercised | $ / shares 18.70
Weighted Average Exercise Price, Forfeited | $ / shares 20.02
Weighted Average Exercise Price, Expired | $ / shares 0
Weighted Average Exercise Price Outstanding at End of Period | $ / shares 26.04
Weighted Average Exercise Price, Exercisable at End of Period | $ / shares 26.04
Weighted Average Exercise Price, Exercisable at End of Period | $ / shares $ 26.04
Remaining Contractual Term Outstanding at End of Period 3 years 2 months 12 days
Remaining Contractual Term Exercisable at End of Period 3 years 2 months 12 days
Share Based Compensation Arrangement By Share Based Payment Award Vested And Expected To Vest Outstanding Remaining Contractual Term 3 years 2 months 12 days
Aggregate Intrinsic Value Outstanding at End of Period | $ $ 88,804
Aggregate Intrinsic Value Exercisable at End of Period | $ 88,804
Aggregate Intrinsic Value Exercisable at End of Period, Vested and expacted | $ $ 88,804